PRESS RELEASE
News
-
-
-
PRESS RELEASE
SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory
SCHOTT Pharma AG & Co. KGaA delivers on 2023 targets with 9% revenue growth to EUR 899m and maintains high EBITDA margin of 26.6%. Strategic shift towards high-value solutions accelerates with strong profitability. -
PRESS RELEASE
Sartorius expects profitable growth in 2024; double-digit annual sales revenue growth projected through to 2028
Sartorius expects profitable growth in 2024 with double-digit annual sales revenue growth projected through to 2028. Sales revenue declined in 2023 due to soft demand and geopolitical uncertainties. Rapid leverage reduction through strong operating cash flow planned. -
PRESS RELEASE
Sartorius Stedim Biotech publie ses résultats préliminaires non audités pour l’exercice 2023 et fournit ses prévisions pour 2024 ainsi que de nouvelles perspectives à moyen terme
Sartorius Stedim Biotech publie ses résultats préliminaires non audités pour l’exercice 2023 et fournit ses prévisions pour 2024 ainsi que de nouvelles perspectives à moyen terme -
PRESS RELEASE
Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook
Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook. The company expects sales revenue growth in the mid to high single-digit percentage range with an underlying profit margin of more than 30 percent. Keywords: Sartorius Stedim Biotech, preliminary results, fiscal 2023, 2024 guidance, midterm outlook. -
PRESS RELEASE
Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth and 29.8% CORE EBITDA Margin
Lonza Group AG reports solid 2023 performance with 10.9% CER sales growth and 29.8% CORE EBITDA margin. Proposed 14% dividend increase and continued growth investment with 2023 CAPEX at 25% of sales. -
-
PRESS RELEASE
DG DEADLINE ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Dollar General Corporation Investors to Secure Counsel Before Important January 26 Deadline in Securities Class Action - DG
Rosen Law Firm reminds Dollar General Corporation investors of the January 26, 2024 lead plaintiff deadline in the securities class action. Investors urged to secure counsel before deadline. -
PRESS RELEASE
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages EHang Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - EH
Rosen Law Firm, a leading investor rights law firm, reminds EHang Holdings Limited investors of the February 2, 2024 lead plaintiff deadline in the securities class action. Investors may be entitled to compensation without payment of any fees or costs through a contingency fee arrangement.
